Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 1 de 1
Filtrar
Más filtros











Base de datos
Intervalo de año de publicación
1.
Am J Physiol Heart Circ Physiol ; 293(6): H3550-7, 2007 Dec.
Artículo en Inglés | MEDLINE | ID: mdl-17906107

RESUMEN

We describe the enzymes that constitute the major bradykinin (BK)-processing pathways in the perfusates of mesenteric arterial bed (MAB) and coronary vessels isolated from Wistar normotensive rats (WNR) and spontaneously hypertensive rats. The contribution of particular proteases to BK degradation was revealed by the combined analysis of fragments generated during incubation of BK with representative perfusate samples and the effect of selective inhibitors on the respective reactions. Marked differences were seen among the perfusates studied; MAB secretes, per minute of perfusion, kininase activity capable of hydrolyzing approximately 300 pmol of BK/min, which is approximately 250-fold larger amount on a per unit time basis than that of its coronary counterpart. BK degradation in the coronary perfusate seems to be mediated by ANG I-converting enzyme, neutral endopeptidase 24.11-like enzyme, and a dl-2-mercaptomethyl-3-guanidinoethylthiopropanoic acid-sensitive basic carboxypeptidase; coronary perfusate of WNR contains an additional BK-degrading enzyme whose specificity resembles that of neurolysin or thimet oligopeptidase. Diversely, a des-Arg(9)-BK-forming enzyme, responsible for nearly all of the kininase activity of MAB perfusates of WNR and spontaneously hypertensive rats, could be purified by a procedure that involved affinity chromatography over potato carboxypeptidase inhibitor-Sepharose column and shown to be structurally identical to rat pancreatic carboxypeptidase B (CPB). Comparable levels of CPB mRNA expression were observed in pancreas, liver, mesentery, and kidney, but very low levels were detected in lung, heart, aorta, and carotid artery. In conclusion, distinct BK-processing pathways operate in the perfusates of rat MAB and coronary bed, with a substantial participation of a des-Arg(9)-BK-forming enzyme identical to pancreatic CPB.


Asunto(s)
Bradiquinina/metabolismo , Carboxipeptidasa B/sangre , Circulación Coronaria , Hipertensión/enzimología , Metaloendopeptidasas/metabolismo , Peptidil-Dipeptidasa A/metabolismo , Circulación Esplácnica , Inhibidores de la Enzima Convertidora de Angiotensina/farmacología , Animales , Presión Sanguínea , Bradiquinina/análogos & derivados , Carboxipeptidasa B/antagonistas & inhibidores , Carboxipeptidasa B/genética , Carboxipeptidasa B/aislamiento & purificación , Modelos Animales de Enfermedad , Regulación Enzimológica de la Expresión Génica , Hidrólisis , Hipertensión/fisiopatología , Masculino , Metaloendopeptidasas/antagonistas & inhibidores , Neprilisina/metabolismo , Páncreas/enzimología , Perfusión , Inhibidores de Proteasas/farmacología , Ratas , Ratas Endogámicas SHR , Ratas Wistar , Especificidad por Sustrato , Distribución Tisular
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA